Keensight Buys Majority Stake in Isto in $1 Billion Deal

European private equity firm Keensight Capital agreed to acquire a majority stake in orthobiologic product maker Isto Biologics from Thompson Street Capital Partners, as the pickup in mid-sized deals continues....

Redirecting to full article...